Novartis
Trending Articles
Related Content
Research & Development
Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture
In collaboration with CPI, Intellegens has secured a grant from Innovate UK to fund a two year project to augment technology that will assist productivity and yields of oligonucleotide therapeutic manufacture
Digital
Made in Switzerland: blockchain enabled healthcare
Interoperable blockchain-enabled solutions could eliminate waste, enhance security and privacy, build trust and, ultimately, benefit patients and the entire pharmaceutical value chain, say the founders of PharmaLedger. Dr Kevin Robinson dialled in to find out more